RxDoctor Payments Data

Joel Idowu, MD

Forensic Psychiatry · Staten Island, NYNPI 1710998778

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.8% of the total across 44 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Alkermes, Inc. at 32.4% of the total. Reporting peaked in 2023 at $354 and has fallen 63.6% since, to $129 in 2025.

$947in general payments, 2019–2025

Across 44 payments — averaging $21.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$306
  • Otsuka America Pharmaceutical, Inc.$237
  • Sunovion Pharmaceuticals Inc.$180
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$87
  • E.r. Squibb & Sons, L.L.C.$75
  • Lundbeck LLC$33
  • plus $30 from 1 others

What the payments were for

  • Food & beverage$88894%
  • Education$596%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$947 in reported general payments places this provider in the 85th percentile of 27 forensic psychiatry providers in New York.

See all forensic psychiatry providers in New York

Medicare billing

Part B allowed, 2024
$25,837
Medicare patients
35
Services billed
218

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl17$5,785
Risperidone174$3,051
Quetiapine Fumarate122$2,494
Asenapine Maleate12$2,207
Fluphenazine Hcl12$1,509
Divalproex Sodium53$1,446
Aripiprazole13$1,384
Haloperidol27$1,361
Benztropine Mesylate80$985
Perphenazine12$772
Fluvoxamine Maleate11$687
Clonazepam87$566
Bupropion Hcl SrBupropion Hcl21$521
Venlafaxine Hcl ErVenlafaxine Hcl39$484
Trazodone Hcl55$442

Paid to pharmacies, not to this prescriber.

Other forensic psychiatry in Staten Island

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →